Vaishali Pharma Limited has announced its audited standalone and consolidated financial results for the quarter and financial year ended 31st March 2026. The company reported a standalone revenue from operations of Rs. 2,692.71 Lakh for the fourth quarter ended 31st March 2026, compared to Rs. 2,465.19 Lakh in the preceding quarter ended 31st December 2025 and Rs. 3,224.58 Lakh in the corresponding quarter of the previous year. The standalone net profit for the quarter stood at Rs. 26.64 Lakh, reflecting a decrease from Rs. 130.14 Lakh in the previous quarter and Rs. 429.25 Lakh in the corresponding quarter of the previous year.
| Particulars | Quarter Ended Mar 31, 2026 | QoQ Growth (%) | YoY Growth (%) |
| Revenue from Operations | 2,692.71 Lakh | 9.23% | -16.50% |
| Net Profit | 26.64 Lakh | -79.53% | -93.79% |
Vaishali Pharma Limited is a pharmaceutical company engaged in the sale of various pharmaceutical products. The company operates as a recognized star export house and is ISO 9001:2015 certified.
Leave a Reply